ArticleBlood2022

Hybrid immunity in immunocompromised patients with CLL after SARS-CoV-2 infection followed by booster mRNA vaccination.

Lisa Blixt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.